GlaxoSmithKline PLC
GSK | IL
Overview
Corporate Details
- ISIN(s):
- GB00BN7SWP63 (+1 more)
- LEI:
- 5493000HZTVUYLO1D793
- Country:
- United Kingdom
- Address:
- 79 NEW OXFORD STREET, WC1A 1DG LONDON
- Website:
- https://www.gsk.com/en-gb/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
GSK is a global biopharmaceutical company dedicated to uniting science, technology, and talent to prevent and treat human disease. The company focuses on the research, development, and manufacturing of innovative vaccines and specialty medicines. Its research and development efforts are concentrated in four primary therapeutic areas: infectious diseases, HIV, oncology, and immunology and respiratory diseases. GSK is committed to expanding global access to its products through responsible pricing, strategic partnerships, and health programs, with a stated ambition to positively impact the health of 2.5 billion people.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for GlaxoSmithKline PLC.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-26 08:00 |
Transaction in Own Shares
Transaction in Own Shares
|
English | 2.3 MB | |
| 2025-08-22 08:00 |
Transaction in Own Shares
Transaction in Own Shares
|
English | 2.3 MB | |
| 2025-08-21 16:30 |
Director's Dealing
Director/PDMR Shareholding
|
English | 20.6 KB | |
| 2025-08-21 08:00 |
Transaction in Own Shares
Transaction in Own Shares
|
English | 1.4 MB | |
| 2025-08-20 08:00 |
Transaction in Own Shares
Transaction in Own Shares
|
English | 1.7 MB | |
| 2025-08-19 16:30 |
Director's Dealing
Director/PDMR Shareholding
|
English | 40.9 KB | |
| 2025-08-19 08:00 |
Transaction in Own Shares
Transaction in Own Shares
|
English | 1.2 MB | |
| 2025-08-18 08:00 |
Transaction in Own Shares
Transaction in Own Shares
|
English | 641.2 KB | |
| 2025-08-15 08:00 |
Transaction in Own Shares
Transaction in Own Shares
|
English | 2.3 MB | |
| 2025-08-14 08:00 |
Transaction in Own Shares
Transaction in Own Shares
|
English | 454.8 KB | |
| 2025-08-13 08:00 |
Transaction in Own Shares
Transaction in Own Shares
|
English | 1.8 MB | |
| 2025-08-12 16:30 |
Director's Dealing
Director/PDMR Shareholding
|
English | 91.5 KB | |
| 2025-08-12 08:00 |
Transaction in Own Shares
Transaction in Own Shares
|
English | 1.5 MB | |
| 2025-08-11 08:00 |
Regulatory News Service
FDA to review gonorrhea indication for gepotidacin
|
English | 31.0 KB | |
| 2025-08-11 08:00 |
Transaction in Own Shares
Transaction in Own Shares
|
English | 1.6 MB |
Automate Your Workflow. Get a real-time feed of all GlaxoSmithKline PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for GlaxoSmithKline PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
